主权项 |
1. A method for treating a subject suffering from, or being at risk of suffering from a disease state or condition mediated by a FGFR kinase, said method comprising administering to the subject a compound selected from the group consisting of a compound of formula (I-A) or formula (I-B): a tautomeric form, stereochemically isomeric form, and isotopic form thereof, wherein each R2 is independently selected from hydroxyl, halogen, cyano, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, C1-4alkoxy, hydroxyC1-4alkyl, hydroxyC1-4alkoxy, haloC1-4alkyl, haloC1-4alkoxy, hydroxyhaloC1-4alkyl, hydroxyhaloC1-4alkoxy, C1-4alkoxyC1-4alkyl, haloC1-4alkoxyC1-4alkyl, C1-4alkoxyC1-4alkyl wherein each C1-4alkyl may optionally be substituted with one or two hydroxyl groups, hydroxyhaloC1-4alkoxyC1-4alkyl, R13, C1-4alkyl substituted with R13, C1-4alkyl substituted with —C(═O)—R13, C1-4alkoxy substituted with R13, C1-4alkoxy substituted with —C(═O)—R13, —C(═O)—R13, C1-4alkyl substituted with —NR7R8, C1-4alkyl substituted with —C(═O)—NR7R8, C1-4alkoxy substituted with —NR7R8, C1-4alkoxy substituted with —C(═O)—NR7R8, —NR7R8 and —C(═O)—NR7R8; or when two R2 groups are attached to adjacent carbon atoms they may be taken together to form a radical of formula:
—O—(C(R17)2)p—O—;—X—CH═CH—; or—X—CH═N—; wherein R17 represents hydrogen or fluorine, p represents 1 or 2 and X represents O or S; Y represents —CR18═N—OR19 or -E-D; D represents a 3 to 12 ring membered monocyclic or bicyclic carbocyclyl or a 3 to 12 ring membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O and S, wherein said carbocyclyl and heterocyclyl may each be optionally substituted by one or more R1 groups; E represents a bond, —(CR22R23)n-, C2-4alkenediyl optionally substituted with R22, C2-4alkynediyl optionally substituted with R22, —CO—(CR22R23)s—, —(CR22R23)s—CO—, —NR22—(CR22R23)s—, —(CR22R23)s—NR22—, —O—(CR22R23)s—, —(CR22R23)s—O—, —S(O)m—(CR22R23)s—, —(CR22R23)s—S(O)m—, —(CR22R23)s—CO—NR22—(CR22R23)s— or —(CR22R23)s—NR22—CO—(CR22R23)s—; R1 represents hydrogen, halo, cyano, C1-6alkyl, C1-6alkoxy, —C(═O)—O—C1-6alkyl, C2-4alkenyl, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl, cyanoC1-4alkyl, C1-6 alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, —NR4R5, C1-6alkyl substituted with —O—C(═O)—C1-6alkyl, C1-6alkyl substituted with —NR4R5, —C(═O)—NR4R5, —C(═O)—C1-6alkyl-NR4R5, C1-6alkyl substituted with —C(═O)—NR4R5, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NR12—S(═O)2—NR14R15, R6, C1-6alkyl substituted with R6, —C(═O)—R6, C1-6alkyl substituted with —C(═O)—R6, hydroxyC1-6alkyl substituted with R6, C1-6alkyl substituted with —Si(CH3)3, C1-6alkyl substituted with —P(═O)(OH)2 or C1-6alkyl substituted with —P(═O)(OC1-6alkyl)2; R3 represents hydroxyl, C1-6alkoxy, hydroxyC1-6alkoxy, C1-6alkoxy substituted with —NR10R11, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl optionally substituted with —O—C(═O)—C1-6alkyl, hydroxyC1-6alkyl optionally substituted with —O—C(═O)—C1-6alkyl, hydroxyC2-6alkenyl, hydroxyC2-6alkynyl, hydroxyhaloC1-6alkyl, cyanoC1-6alkyl, C1-6alkyl substituted with carboxyl, C1-6alkyl substituted with —C(═O)—C1-6alkyl, C1-6alkyl substituted with —C(═O)—O—C1-6alkyl, C1-6alkyl substituted with C1-6alkoxyC1-6alkyl-O—C(═O)—, C1-6alkyl substituted with C1-6alkoxyC1-6alkyl-C(═O)—, C1-6alkyl substituted with —O—C(═O)—C1-6alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups or with —O—C(═O)—C1-6alkyl, C2-6alkenyl substituted with C1-6alkoxy, C2-6alkynyl substituted with C1-6alkoxy, C1-6alkyl substituted with R9 and optionally substituted with —O—C(═O)—C1-6alkyl, C1-6alkyl substituted with —C(═O)—R9, C1-6alkyl substituted with hydroxyl and R9, C2-6alkenyl substituted with R9, C2-6alkynyl substituted with R9, C1-6alkyl substituted with —NR10R11, C2-6alkenyl substituted with —NR10R11, C2-6alkynyl substituted with —NR10R11, C1-6alkyl substituted with hydroxyl and —NR10R11, C1-6alkyl substituted with one or two halogens and —NR10R11, —C1-6alkyl-C(R12)═N—O—R12, C1-6alkyl substituted with —C(═O)—NR10R11, C1-6alkyl substituted with —O—C(═O)—NR10R11, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NR12—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NR12—S(═O)2—NR14R15, R13, C1-6alkyl substituted with —P(═O)(OH)2 or C1-6alkyl substituted with —P(═O)(OC1-6alkyl)2; R4 and R5 each independently represent hydrogen, C1-6alkyl, C1-6alkyl substituted with —NR14R15, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, —C(═O)—NR14R15, —C(═O)—O—C1-6alkyl, —C(═O)—R13, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NH— S(═O)2—NR14R15, R13 or C1-6alkyl substituted with R13; R6 represents C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, 4 to 7-membered monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S; said C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, 4 to 7-membered monocyclic heterocyclyl, optionally and each independently being substituted by 1, 2, 3, 4 or 5 substituents, each substituent independently being selected from cyano, C1-6alkyl, cyanoC1-6alkyl, hydroxyl, carboxyl, hydroxyC1-6alkyl, halogen, haloC1-6alkyl, hydroxyhaloC1-6alkyl, C1-6alkoxy, C1-6alkoxyC1-6alkyl, C1-6alkyl-O—C(═O)—, —NR14R15, —C(═O)—NR14R15, C1-6alkyl substituted with —NR14R15, C1-6alkyl substituted with —C(═O)—NR14R15, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl and C1-6alkyl substituted with —NH—S(═O)2—NR14R15; R7 and R8 each independently represent hydrogen, C1-6alkyl, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl or C1-6alkoxyC1-6alkyl; R9 represents C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, naphthyl, or 3 to 12 membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O and S, said C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, naphthyl, or 3 to 12 membered monocyclic or bicyclic heterocyclyl each optionally and each independently being substituted with 1, 2, 3, 4 or 5 substituents, each substituent independently being selected from ═O, C1-4alkyl, hydroxyl, carboxyl, hydroxyC1-4alkyl, cyano, cyanoC1-4alkyl, C1-4alkyl-O—C(═O)—, C1-4alkyl substituted with C1-4alkyl-O—C(═O)—, C1-4alkyl-C(═O)—, C1-4 alkoxyC1-4alkyl wherein each C1-4alkyl may optionally be substituted with one or two hydroxyl groups, halogen, haloC1-4alkyl, hydroxyhaloC1-4alkyl, —NR14R15, —C(═O)—NR14R15, C1-4alkyl substituted with —NR14R15, C1-4alkyl substituted with —C(═O)—NR14R15, C1-4alkoxy, —S(═O)2—C1-4alkyl, —S(═O)2-haloC1-4alkyl, —S(═O)2—NR14R15, C1-4alkyl substituted with —S(═O)2—NR14R15, C1-4alkyl substituted with —NH—S(═O)2—C1-4alkyl, C1-4 alkyl substituted with —NH—S(═O)2-haloC1-4alkyl, C1-4alkyl substituted with —NH—S(═O)2—NR14R15, R13, —C(═O)—R13, C1-4alkyl substituted with R13, phenyl optionally substituted with R16, phenylC1-6alkyl wherein the phenyl is optionally substituted with R16, a 5 or 6-membered aromatic monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S wherein said heterocyclyl is optionally substituted with R16; or when two of the substituents of R9 are attached to the same atom, they may be taken together to form a 4 to 7-membered saturated monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S; R10 and R11 each independently represent hydrogen, carboxyl, C1-6alkyl, cyanoC1-6alkyl, C1-6alkyl substituted with —NR14R15, C1-6alkyl substituted with —C(═O)—NR14R15, haloC1-6alkyl, hydroxyC1-6alkyl, hydroxyhaloC1-6alkyl, C1-6alkoxy, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, R6, C1-6 alkyl substituted with R6, —C(═O)—R6, —C(═O)—C1-6alkyl, —C(═O)-hydroxyC1-6alkyl, —C(═O)-haloC1-6alkyl, —C(═O)-hydroxyhaloC1-6alkyl, C1-6alkyl substituted with —Si(CH3)3, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with carboxyl, or C1-6 alkyl substituted with —NH—S(═O)2—NR14R15; R12 represents hydrogen or C1-4alkyl optionally substituted with C1-4alkoxy; R13 represents C3-8cycloalkyl or a saturated 4 to 6-membered monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S, wherein said C3-8cycloalkyl or monocyclic heterocyclyl is optionally substituted with 1, 2 or 3 substituents each independently selected from halogen, hydroxyl, C1-6alkyl, haloC1-6alkyl, ═O, cyano, —C(═O)—C1-6alkyl, C1-6alkoxy, and —NR14R15; R14 and R15 each independently represent hydrogen, or haloC1-4alkyl, or C1-4alkyl optionally substituted with a substituent selected from hydroxyl, C1-4alkoxy, amino and mono- or di(C1-4alkyl)amino; R16 represents hydroxyl, halogen, cyano, C1-4alkyl, C1-4alkoxy, —NR14R15 or —C(═O)NR14R15; R18 represents hydrogen, C1-6 alkyl, C3-8 cycloalkyl, C1-4alkyl substituted with C3-8 cycloalkyl; R19 represents hydrogen; C1-6 alkyl; C3-8 cycloalkyl; C1-6alkyl substituted with —O—R20; —(CH2)r-CN; —(CH2)r—CONR20R21; —(CH2)r1—NR20R21; —(CH2)r1—NR20COR21; —(CH2)r1—NR20—(CH2)s—SO2—R21; —(CH2)r1—NH—SO2—NR20R21; —(CH2)r1—NR20CO2R21; —(CH2)r—SO2NR20R21; phenyl optionally substituted with 1, 2, 3, 4 or 5 substituents each independently selected from halogen, C1-4alkyl, C1-4alkyloxy, cyano and amino; a 5- or 6-membered aromatic monocyclic heterocycle containing at least one heteroatom selected from N, O and S, said heterocycle being optionally substituted with 1, 2, 3 or 4 substituents each independently selected from halogen, C1-4alkyl, C1-4alkyloxy, cyano and amino; wherein said C1-6 alkyl and C3-8 cycloalkyl, may be optionally substituted by one or more R20 groups; R20 and R21 independently represent hydrogen, C1-6 alkyl, C1-6 alkanol —(CH2)n—O—C1-6alkyl, or when attached to a nitrogen atom R20 and R21 can be taken together to form with the nitrogen atom to which they are attached a monocyclic saturated 4, 5 or 6-membered ring which optionally contains a further heteroatom selected from O, S and N; R22 and R23 independently represent hydrogen, C1-6 alkyl, or hydroxyC1-6alkyl; m independently represents 0, 1 or 2; n independently represents 0, 1, 2, 3 or 4; s independently represents 0, 1, 2, 3 or 4; r independently represents 1, 2, 3, or 4; r1 independently represents 2, 3 or 4; or an N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof. |